283 related articles for article (PubMed ID: 31423502)
1. Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy.
Agarwal S; Mohamed MS; Mizuki T; Maekawa T; Sakthi Kumar D
J Mater Chem B; 2019 Oct; 7(39):5896-5919. PubMed ID: 31423502
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-
Banstola A; Duwa R; Emami F; Jeong JH; Yook S
Mol Pharm; 2020 Nov; 17(11):4386-4400. PubMed ID: 33079558
[TBL] [Abstract][Full Text] [Related]
3. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M
ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
5. Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles.
Sousa F; Dhaliwal HK; Gattacceca F; Sarmento B; Amiji MM
J Control Release; 2019 Sep; 309():37-47. PubMed ID: 31344424
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent magnetic PEI-PLGA nanoparticles loaded with paclitaxel for concurrent cell imaging, enhanced apoptosis and autophagy in human brain cancer.
Wang X; Yang L; Zhang H; Tian B; Li R; Hou X; Wei F
Colloids Surf B Biointerfaces; 2018 Dec; 172():708-717. PubMed ID: 30245296
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
[TBL] [Abstract][Full Text] [Related]
8. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration.
Caban-Toktas S; Sahin A; Lule S; Esendagli G; Vural I; Karlı Oguz K; Soylemezoglu F; Mut M; Dalkara T; Khan M; Capan Y
Int J Pharm; 2020 Mar; 578():119076. PubMed ID: 31988035
[TBL] [Abstract][Full Text] [Related]
9. Intranasal delivery of cancer-targeting doxorubicin-loaded PLGA nanoparticles arrests glioblastoma growth.
Chung K; Ullah I; Kim N; Lim J; Shin J; Lee SC; Jeon S; Kim SH; Kumar P; Lee SK
J Drug Target; 2020 Jul; 28(6):617-626. PubMed ID: 31852284
[TBL] [Abstract][Full Text] [Related]
10. Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapy.
Mu Q; Jeon M; Hsiao MH; Patton VK; Wang K; Press OW; Zhang M
Adv Healthc Mater; 2015 Jun; 4(8):1236-45. PubMed ID: 25761648
[TBL] [Abstract][Full Text] [Related]
11. Time-Resolved MRI Assessment of Convection-Enhanced Delivery by Targeted and Nontargeted Nanoparticles in a Human Glioblastoma Mouse Model.
Stephen ZR; Chiarelli PA; Revia RA; Wang K; Kievit F; Dayringer C; Jeon M; Ellenbogen R; Zhang M
Cancer Res; 2019 Sep; 79(18):4776-4786. PubMed ID: 31331912
[TBL] [Abstract][Full Text] [Related]
12. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
14. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.
Dhami NK; Pandey RS; Jain UK; Chandra R; Madan J
J Microencapsul; 2014; 31(7):685-93. PubMed ID: 24963955
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma multiforme targeted therapy: The Chlorotoxin story.
Cohen-Inbar O; Zaaroor M
J Clin Neurosci; 2016 Nov; 33():52-58. PubMed ID: 27452128
[TBL] [Abstract][Full Text] [Related]
16. Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells.
Ramalho MJ; Bravo M; Loureiro JA; Lima J; Pereira MC
Life Sci; 2022 May; 296():120435. PubMed ID: 35247437
[TBL] [Abstract][Full Text] [Related]
17. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
[TBL] [Abstract][Full Text] [Related]
18. Chlorotoxin-conjugated nanoparticles for targeted imaging and therapy of glioma.
Zhao L; Shi X; Zhao J
Curr Top Med Chem; 2015; 15(13):1196-208. PubMed ID: 25858130
[TBL] [Abstract][Full Text] [Related]
19. Combination treatment with theranostic nanoparticles for glioblastoma sensitization to TMZ.
Yoo B; Ifediba MA; Ghosh S; Medarova Z; Moore A
Mol Imaging Biol; 2014 Oct; 16(5):680-9. PubMed ID: 24696184
[TBL] [Abstract][Full Text] [Related]
20. Preparation of Cholera Toxin Subunit B Functionalized Nanoparticles for Targeted Therapy of Glioblastoma.
Guan J; Qian J; Zhan C
Methods Mol Biol; 2020; 2059():207-212. PubMed ID: 31435923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
